Evidence map›Paper›PMID 23262074›Full record

ArticleAnalytical biochemistry2013

Microscale separation of heparosan, heparan sulfate, and heparin.

Xue Zhao, Bo Yang, Kathryn Linkens, Payel Datta, Akihiro Onishi, Fuming Zhang, Robert J Linhardt

Abstract read
In one paragraph

Article in Analytical biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xue ZhaoCollege of Food Science and Technology, Ocean University of China, Qingdao 266003, People's Republic of China.
Bo Yang
Kathryn Linkens
Payel Datta
Akihiro Onishi
Fuming Zhang
Robert J Linhardt

Funding

Development of a Bioengineered Heparin from a Non-Animal SourceR01HL096972 · NHLBI · RENSSELAER POLYTECHNIC INSTITUTE · PI DORDICK, JONATHAN S., LINHARDT, ROBERT J · 2009 to 2013
$3.9M
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANSR01GM038060 · NIGMS · UNIVERSITY OF IOWA · PI LINHARDT, ROBERT J · 1988 to 2012
$2.8M
Characterization of Anticoagulant Heparin and Related PolysaccharidesRC2HL101721 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LINHARDT, ROBERT J, SASISEKHARAN, RAM · 2009 to 2010
$1.3M
Metabolic Engineering of Chinese Hamster Ovary Cells for Production of HeparinR01GM090127 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SHARFSTEIN, SUSAN T · 2009 to 2011
$1.0M
NHLBI NIH HHS HL096972NHLBI NIH HHS HL101721NHLBI NIH HHS R01 HL096972NHLBI NIH HHS RC2 HL101721NIGMS NIH HHS GM090127NIGMS NIH HHS GM38060NIGMS NIH HHS R01 GM038060NIGMS NIH HHS R01 GM090127
6 · The paper itself

Abstract

The separation and quantification of glycosaminoglycan (GAG) chains with different levels of sulfation from cells and media, and prepared through chemoenzymatic synthesis or metabolic engineering, pose a major challenge in glycomics analysis. A method for microscale separation and quantification of heparin, heparan sulfate, and heparosan from cells is reported. This separation relies on a mini strong anion exchange spin column eluted stepwise with various concentrations of sodium chloride. Disaccharide analysis by LC-MS was used to monitor the chemical structure of the various GAG chains that were recovered.

Indexed as

AnimalsChemistry Techniques, AnalyticalCHO CellsCricetinaeDisaccharidesHeparan SulfateHeparinDisaccharidesHeparan SulfateHeparinheparosan

Identifiers

PMID23262074
PMCPMC3572195

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.